Nuclear Medicine Radioisotopes Market Report

Global and Region Nuclear Medicine Radioisotopes Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：174
  • REPORT CODE：GMM1002159
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics.

    The report details the trend, potential and market size of Nuclear Medicine Radioisotopes market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Nuclear Medicine Radioisotopesmarket, defines the market attractiveness level of Nuclear Medicine Radioisotopes market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Nuclear Medicine Radioisotopes industry, describes the types of Nuclear Medicine Radioisotopes market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nuclear Medicine Radioisotopes market and the development prospects and opportunities of Nuclear Medicine Radioisotopes industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nuclear Medicine Radioisotopes market in Chapter 13.

    By Player:

    • Segami

    • Positron

    • Cardinal Health

    • Agfa-Gevaert Group

    • Cardiarc

    • NTP Radioisotopes SOC

    • Braco

    • Nordion (Canada)

    • Digirad

    • GE Healthcare

    • Curium

    • Siemens Healthcare

    By Type:

    • Thallium-201 (Tl-201)

    • Iodine (I-123)

    • Fluorine-18

    • Rubidium-82 (Rb-82)

    • Other

    By End-User:

    • Tumor

    • Heart Disease

    • Lymphoma

    • Thyroid Gland

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Nuclear Medicine Radioisotopes Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Nuclear Medicine Radioisotopes Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Nuclear Medicine Radioisotopes Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Nuclear Medicine Radioisotopes Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Nuclear Medicine Radioisotopes Market Analysis and Outlook to 2022

    • 7.1 Global Nuclear Medicine Radioisotopes Consumption (2017-2022)

    • 7.2 United States Nuclear Medicine Radioisotopes Consumption (2017-2022)

    • 7.3 Europe Nuclear Medicine Radioisotopes Consumption (2017-2022)

    • 7.4 China Nuclear Medicine Radioisotopes Consumption (2017-2022)

    • 7.5 Japan Nuclear Medicine Radioisotopes Consumption (2017-2022)

    • 7.6 India Nuclear Medicine Radioisotopes Consumption (2017-2022)

    • 7.7 South Korea Nuclear Medicine Radioisotopes Consumption (2017-2022)

    8 Region and Country-wise Nuclear Medicine Radioisotopes Market Analysis and Outlook to 2028

    • 8.1 Global Nuclear Medicine Radioisotopes Consumption Forecast (2022-2028)

    • 8.2 United States Nuclear Medicine Radioisotopes Consumption Forecast (2022-2028)

    • 8.3 Europe Nuclear Medicine Radioisotopes Consumption Forecast (2022-2028)

    • 8.4 China Nuclear Medicine Radioisotopes Consumption Forecast (2022-2028)

    • 8.5 Japan Nuclear Medicine Radioisotopes Consumption Forecast (2022-2028)

    • 8.6 India Nuclear Medicine Radioisotopes Consumption Forecast (2022-2028)

    • 8.7 South Korea Nuclear Medicine Radioisotopes Consumption Forecast (2022-2028)

    9 Global Nuclear Medicine Radioisotopes Market Outlook by Types and Applications to 2022

    • 9.1 Global Nuclear Medicine Radioisotopes Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Thallium-201 (Tl-201) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Iodine (I-123) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Fluorine-18 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Rubidium-82 (Rb-82) Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Nuclear Medicine Radioisotopes Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Tumor Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Heart Disease Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Lymphoma Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Thyroid Gland Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Nuclear Medicine Radioisotopes Market Outlook by Types and Applications to 2028

    • 10.1 Global Nuclear Medicine Radioisotopes Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Thallium-201 (Tl-201) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Iodine (I-123) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Fluorine-18 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Rubidium-82 (Rb-82) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Nuclear Medicine Radioisotopes Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Tumor Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Heart Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Thyroid Gland Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Nuclear Medicine Radioisotopes Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Nuclear Medicine Radioisotopes Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Nuclear Medicine Radioisotopes Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Nuclear Medicine Radioisotopes Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Nuclear Medicine Radioisotopes Market Competitive Analysis

    • 14.1 Segami

      • 14.1.1 Segami Company Details

      • 14.1.2 Segami Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Segami Nuclear Medicine Radioisotopes Product and Service

    • 14.2 Positron

      • 14.2.1 Positron Company Details

      • 14.2.2 Positron Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Positron Nuclear Medicine Radioisotopes Product and Service

    • 14.3 Cardinal Health

      • 14.3.1 Cardinal Health Company Details

      • 14.3.2 Cardinal Health Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Cardinal Health Nuclear Medicine Radioisotopes Product and Service

    • 14.4 Agfa-Gevaert Group

      • 14.4.1 Agfa-Gevaert Group Company Details

      • 14.4.2 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product and Service

    • 14.5 Cardiarc

      • 14.5.1 Cardiarc Company Details

      • 14.5.2 Cardiarc Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Cardiarc Nuclear Medicine Radioisotopes Product and Service

    • 14.6 NTP Radioisotopes SOC

      • 14.6.1 NTP Radioisotopes SOC Company Details

      • 14.6.2 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product and Service

    • 14.7 Braco

      • 14.7.1 Braco Company Details

      • 14.7.2 Braco Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Braco Nuclear Medicine Radioisotopes Product and Service

    • 14.8 Nordion (Canada)

      • 14.8.1 Nordion (Canada) Company Details

      • 14.8.2 Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Nordion (Canada) Nuclear Medicine Radioisotopes Product and Service

    • 14.9 Digirad

      • 14.9.1 Digirad Company Details

      • 14.9.2 Digirad Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Digirad Nuclear Medicine Radioisotopes Product and Service

    • 14.10 GE Healthcare

      • 14.10.1 GE Healthcare Company Details

      • 14.10.2 GE Healthcare Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 GE Healthcare Nuclear Medicine Radioisotopes Product and Service

    • 14.11 Curium

      • 14.11.1 Curium Company Details

      • 14.11.2 Curium Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Curium Nuclear Medicine Radioisotopes Product and Service

    • 14.12 Siemens Healthcare

      • 14.12.1 Siemens Healthcare Company Details

      • 14.12.2 Siemens Healthcare Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Siemens Healthcare Nuclear Medicine Radioisotopes Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Nuclear Medicine Radioisotopes

    • Figure Nuclear Medicine Radioisotopes Picture

    • Table Global Nuclear Medicine Radioisotopes Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nuclear Medicine Radioisotopes Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nuclear Medicine Radioisotopes Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Nuclear Medicine Radioisotopes Consumption by Country (2017-2022)

    • Figure United States Nuclear Medicine Radioisotopes Consumption and Growth Rate (2017-2022)

    • Table Europe Nuclear Medicine Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure China Nuclear Medicine Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Japan Nuclear Medicine Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure India Nuclear Medicine Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure South Korea Nuclear Medicine Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Global Nuclear Medicine Radioisotopes Consumption Forecast by Country (2022-2028)

    • Figure United States Nuclear Medicine Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Nuclear Medicine Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Nuclear Medicine Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Nuclear Medicine Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Nuclear Medicine Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Nuclear Medicine Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Thallium-201 (Tl-201) Consumption and Growth Rate (2017-2022)

    • Figure Global Iodine (I-123) Consumption and Growth Rate (2017-2022)

    • Figure Global Fluorine-18 Consumption and Growth Rate (2017-2022)

    • Figure Global Rubidium-82 (Rb-82) Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor Consumption and Growth Rate (2017-2022)

    • Figure Global Heart Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Lymphoma Consumption and Growth Rate (2017-2022)

    • Figure Global Thyroid Gland Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Thallium-201 (Tl-201) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Iodine (I-123) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fluorine-18 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rubidium-82 (Rb-82) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tumor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Heart Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Thyroid Gland Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Nuclear Medicine Radioisotopes Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Nuclear Medicine Radioisotopes Export by Region (Top 5 Countries) (2017-2028)

    • Table Segami (Foundation Year, Company Profile and etc.)

    • Table Segami Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Segami Nuclear Medicine Radioisotopes Product and Service

    • Table Positron (Foundation Year, Company Profile and etc.)

    • Table Positron Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Positron Nuclear Medicine Radioisotopes Product and Service

    • Table Cardinal Health (Foundation Year, Company Profile and etc.)

    • Table Cardinal Health Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cardinal Health Nuclear Medicine Radioisotopes Product and Service

    • Table Agfa-Gevaert Group (Foundation Year, Company Profile and etc.)

    • Table Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product and Service

    • Table Cardiarc (Foundation Year, Company Profile and etc.)

    • Table Cardiarc Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cardiarc Nuclear Medicine Radioisotopes Product and Service

    • Table NTP Radioisotopes SOC (Foundation Year, Company Profile and etc.)

    • Table NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product and Service

    • Table Braco (Foundation Year, Company Profile and etc.)

    • Table Braco Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Braco Nuclear Medicine Radioisotopes Product and Service

    • Table Nordion (Canada) (Foundation Year, Company Profile and etc.)

    • Table Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nordion (Canada) Nuclear Medicine Radioisotopes Product and Service

    • Table Digirad (Foundation Year, Company Profile and etc.)

    • Table Digirad Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Digirad Nuclear Medicine Radioisotopes Product and Service

    • Table GE Healthcare (Foundation Year, Company Profile and etc.)

    • Table GE Healthcare Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Nuclear Medicine Radioisotopes Product and Service

    • Table Curium (Foundation Year, Company Profile and etc.)

    • Table Curium Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Curium Nuclear Medicine Radioisotopes Product and Service

    • Table Siemens Healthcare (Foundation Year, Company Profile and etc.)

    • Table Siemens Healthcare Nuclear Medicine Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthcare Nuclear Medicine Radioisotopes Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US